AlphaFold predicted structure
GALM · Q96C23

Mean pLDDT
97.8/ 100
Very high
342 residues
Confidence breakdown
- Very high(≥ 90)99%
- Confident(70–90)2%
- Low(50–70)0%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
galactose mutarotase
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Cholestasis
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalNeonatal cholestasis
BIALLELIC, autosomal or pseudoautosomalBilateral congenital or childhood onset cataracts
BIALLELIC, autosomal or pseudoautosomalgalactosemia 4
Abnormality of the skeletal system
hypothyroidism
nerve plexus disorder
skin disorder
Alzheimer disease
alcohol drinking
nutritional deficiency disease
Genu varum
Genu valgum
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Galactose mutarotase
Mutarotase that catalyzes the interconversion of beta-D-galactose and alpha-D-galactose during galactose metabolism (PubMed:12753898). Beta-D-galactose is metabolized in the liver into glucose 1-phosphate, the primary metabolic fuel, by the action of four enzymes that constitute the Leloir pathway: GALM, GALK1 (galactokinase), GALT (galactose-1-phosphate uridylyltransferase) and GALE (UDP-galactose-4'-epimerase) (PubMed:30451973). Involved in the maintenance of the equilibrium between the beta- and alpha-anomers of galactose, therefore ensuring a sufficient supply of the alpha-anomer for GALK1 (PubMed:12753898). Also active on D-glucose although shows a preference for galactose over glucose (PubMed:12753898)
GALM · Q96C23

Mean pLDDT
97.8/ 100
Very high
342 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0